Postoperative Analgesia in Bilateral Knee Arthroplasties

January 12, 2025 updated by: Merve Yazici Kara, Kocaeli City Hospital

Postoperative Analgesia in Bilateral Knee Arthroplasties:Suprainguinal Fascia Iliaca Compartment Block and Local Infiltration Analgesia

To observationally compare the analgesic efficacy of LIA and S-FICB techniques and to record the pain scores of patients who underwent bilateral knee operations in the postoperative period.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Kocaeli, Turkey
        • Kocaeli City Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Patients aged 18-75 years, who planned elective bilateral knee arthroplasty under spinal anesthesia, American Society of Anesthesiologists (ASA) risk score I-II.

Description

Inclusion Criteria:

  • Planned elective bilateral knee arthroplasty under spinal anesthesia
  • American Society of Anesthesiologists (ASA) risk score I-II
  • Patients aged 18-75 years

Exclusion Criteria:

  • Those receiving general anesthesia,
  • Those with epidural catheters,
  • Those who refused to participate in the study,
  • Those whose spinal anesthesia failed and returned to general anesthesia,
  • Those with a body mass index (BMI) >30 kg/m2,
  • History of chronic opioid or corticosteroid use,
  • Patients with psychiatric or neurological problems that would not allow assessment of pain using a visual analog scale (VAS) will be excluded.
  • In addition, patients whose surgery lasted <40 minutes or >120 minutes will also be excluded to keep the data homogeneous.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Grup-1: Suprainguinal fascia iliaca compartment block
Procedure: Bilateral Suprainguinal fascia iliaca compartment block
Suprainguinal fascia iliaca compartment block (S-FICB) is one of the commonly used regional analgesia techniques for postoperative analgesia in lower extremity surgeries.
Grup-2: Local infiltration analgesia
Procedure: Local infiltration analgesia
Local infiltration analgesia is applied to the posterior part of the knee, including the periosteum, ligaments, muscle and/or skin area before closing the surgical field.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Suprainguinal fascia iliaca compartment block (S-FICB) produces adequate analgesic effect in knee arthroplasty.
Time Frame: 4 months
The aim of this study was to observationally compare the analgesic efficacy of local infiltration analgesia (LIA) and suprainguinal fascia iliaca compartment block (S-FICB) techniques in patients who underwent bilateral knee operations. Postoperative pain follow-up of the patients will be done by recording Visual analog scales (VAS) at 4, 8, 12 and 24 hours. Additional analgesic needs and unwanted side effects will also be recorded.
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kocaeli City Hospital

Investigators

  • Principal Investigator: Merve Yazici Kara, MD, Kocaeli City Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Actual)

May 1, 2024

Study Completion (Actual)

June 30, 2024

Study Registration Dates

First Submitted

March 14, 2024

First Submitted That Met QC Criteria

April 4, 2024

First Posted (Actual)

April 10, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 12, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2023-40

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Clinical Trials on Bilateral Suprainguinal fascia iliaca compartment block

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe